BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32800318)

  • 1. [Atrial fibrillation and QT prolongation due to proton pump inhibitor-induced hypomagnesemia].
    Noirclerc N; Delfanne C; Dompnier A
    Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):201-203. PubMed ID: 32800318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.
    Uehara A; Kita Y; Sumi H; Shibagaki Y
    Intern Med; 2019 Aug; 58(15):2201-2205. PubMed ID: 30996187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
    Chrysant SG; Chrysant GS
    Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
    [No Abstract]   [Full Text] [Related]  

  • 4. [A patient with inflammatory arthralgia, paraesthesia and atrial fibrillation].
    Vossen D; Nehls V
    Z Rheumatol; 2020 Feb; 79(1):78-82. PubMed ID: 31776649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
    Swaminathan K
    Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia.
    Civardi C; Collini A; Geda C
    Parkinsonism Relat Disord; 2020 Mar; 72():80-81. PubMed ID: 32146379
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hypomagnesaemia due to proton pump inhibitor use].
    van den Berg S; Scheer MLJ; Holman ND
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT interval resembling long QT syndrome in a newborn with electrolyte dysbalance.
    Ayangade-Johnson G; Villafane J
    J Ky Med Assoc; 2001 Jul; 99(7):285-7. PubMed ID: 11468869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurological symptoms of hypomagnesemia].
    Cakici M; van Steenkiste J; Assink JH; Moudrous W
    Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesemia associated with a proton pump inhibitor.
    Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H
    Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy.
    Cabras P; Anedda M; Caddeo L; Francesco M; Antonella M
    Am J Ther; 2020; 27(6):e676-e680. PubMed ID: 31425160
    [No Abstract]   [Full Text] [Related]  

  • 18. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.